Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Occludin antibody (AA 358-520)

This Rabbit Polyclonal antibody specifically detects Occludin in WB, IHC, ELISA and IP. It exhibits reactivity toward Human, Mouse and Rat.
Catalog No. ABIN7874285
$625.62
Plus shipping costs $50.00
100 μg
Shipping to: United States
Delivery in 2 to 4 Business Days

Quick Overview for Occludin antibody (AA 358-520) (ABIN7874285)

Target

See all Occludin (OCLN) Antibodies
Occludin (OCLN)

Reactivity

  • 147
  • 76
  • 59
  • 34
  • 18
  • 14
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
Human, Mouse, Rat

Host

  • 109
  • 43
  • 4
  • 1
Rabbit

Clonality

  • 90
  • 67
Polyclonal

Conjugate

  • 82
  • 10
  • 6
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This Occludin antibody is un-conjugated

Application

  • 127
  • 42
  • 41
  • 39
  • 26
  • 26
  • 26
  • 24
  • 20
  • 10
  • 10
  • 6
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunoprecipitation (IP)
  • Binding Specificity

    • 33
    • 16
    • 16
    • 12
    • 9
    • 6
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 358-520

    Purpose

    OCLN Antibody / Occludin

    Purification

    Immunogen affinity purified

    Immunogen

    E.coli-derived human Occludin/OCLN recombinant protein (Position: S358-Q520) was used as the immunogen for the OCLN antibody.

    Isotype

    IgG
  • Application Notes

    Optimal dilution of the OCLN antibody should be determined by the researcher.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL

    Buffer

    Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.

    Storage

    4 °C,-20 °C

    Storage Comment

    After reconstitution, the OCLN antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
  • Target

    Occludin (OCLN)

    Alternative Name

    OCLN

    Background

    The OCLN antibody targets Occludin, a key integral membrane protein encoded by the OCLN gene that contributes to tight junction formation and epithelial barrier integrity. Occludin is a 59 kDa tetraspan protein localized at intercellular junctions of epithelial and endothelial cells. It works together with claudins, junctional adhesion molecules (JAMs), and cytoplasmic scaffolding proteins such as ZO-1 to form the tight junction complex that regulates paracellular permeability. The OCLN antibody enables specific detection of Occludin, allowing researchers to investigate the molecular architecture of tight junctions and how their disruption contributes to disease.

    Occludin plays a central role in maintaining cell polarity, barrier selectivity, and communication between adjacent cells. It acts as both a structural and signaling molecule, participating in pathways that control cell growth and differentiation. Phosphorylation of Occludin on serine, threonine, or tyrosine residues dynamically regulates its interaction with cytoplasmic partners and influences tight junction assembly and disassembly. The OCLN antibody is an essential reagent for tracking these modifications and monitoring Occludin redistribution during epithelial remodeling or inflammation.

    Mutations in OCLN cause band-like calcification with simplified gyration and polymicrogyria (BLC-PMG), a neurological disorder associated with cortical malformations and hepatic dysfunction. These findings underscore the systemic importance of Occludin beyond epithelial physiology. The OCLN antibody provides researchers with a means to quantify protein levels in both brain and peripheral tissues, aiding studies into developmental and metabolic roles of tight junction components.

    Occludin dysfunction is also implicated in a range of diseases, including cancer metastasis, viral infection, and inflammatory bowel disease. Pathogens such as hepatitis C virus and cytomegalovirus exploit Occludin to gain cellular entry or modulate junction integrity. Altered Occludin expression can weaken epithelial barriers, promoting invasion or chronic inflammation. The OCLN antibody allows visualization of these alterations in tissue models, helping elucidate how tight junction disruption contributes to pathogenesis.

    The OCLN antibody performs effectively in immunofluorescence microscopy, immunohistochemistry, and western blotting. In epithelial cultures, staining reveals tight junction localization, while in tissues it highlights barrier organization across endothelium and epithelia. NSJ Bioreagents provides this reagent with validated specificity and reliability for studying Occludin regulation, trafficking, and function. By supporting detailed investigation of tight junction biology, the OCLN antibody helps clarify molecular mechanisms that preserve epithelial homeostasis and their perturbation in human disease.

    UniProt

    Q16625

    Pathways

    Cell-Cell Junction Organization, Hepatitis C
You are here:
Chat with us!